Off-target testing for gene-edited allogeneic CAR T cells

Authors

• Fuxin Shi, Legend Biotech, USAFollow
• Qianhua Dong, Technology Development, Legend Biotech, 2101 Cottontail Ln, Somerset, NJ 08873, USA
• Guowei Fang, Technology Development, Legend Biotech, 2101 Cottontail Ln, Somerset, NJ 08873, USA
• Thomas Brieva, Technology Development, Legend Biotech, 2101 Cottontail Ln, Somerset, NJ 08873, USA
• Zhaohui Zheng, Technology Development, Legend Biotech, 2101 Cottontail Ln, Somerset, NJ 08873, USA
• Joeseph Sherba, Technology Development, Legend Biotech, 2101 Cottontail Ln, Somerset, NJ 08873, USA
• Lingling Fan, Technology Development, Legend Biotech, 2101 Cottontail Ln, Somerset, NJ 08873, USA
• Monami Chakraborty, Technology Development, Legend Biotech, 2101 Cottontail Ln, Somerset, NJ 08873, USA
• Candace Tang, Technology Development, Legend Biotech, 2101 Cottontail Ln, Somerset, NJ 08873, USA

Conference Dates

February 1 – 5, 2026

Abstract

Please click Additional Files below to see the full abstract

Recommended Citation

Fuxin Shi, Qianhua Dong, Guowei Fang, Thomas Brieva, Zhaohui Zheng, Joeseph Sherba, Lingling Fan, Monami Chakraborty, and Candace Tang, "Off-target testing for gene-edited allogeneic CAR T cells" in "Advancing Manufacture of Cell and Gene Therapies IX", John Moscariello, Neuvogen, USA Corinne Hoesli, McGill University, Canada Bruno Marques, Century Therapeutics, USA Eds, ECI Symposium Series, (2026). https://dc.engconfintl.org/cell_gene_therapies_ix/45